A post-marketing survey evaluating the safety and efficacy of a fixed-dose single-pill combination of cilnidipine and valsartan in patients with hypertension: Real-world JSH 2014 and 2019 implementations

Matsuda, S; Nagahama, S; Kurose, Y; Wakabayashi, M; Sugii, H; Teshima, T; Suzuki, N; Kario, K

Matsuda, S (corresponding author), EA Pharma Co Ltd, Med Dept, Postmkt Med Res Grp, Chuo Ku, 2-1-1 Irifune, Tokyo 1040042, Japan.

CLINICAL AND EXPERIMENTAL HYPERTENSION, 2020; 42 (6): 502

Abstract

Methods: The home blood pressure control by a single-pill combination of cilnidipine and valsartan (HOPE-Combi) survey sought to evaluate the safety a......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索